Attenuation of diet-induced weight gain and adiposity through increased energy expenditure in mice lacking angiotensin II type 1a receptor

被引:132
作者
Kouyama, R
Suganami, T
Nishida, J
Tanaka, M
Toyoda, T
Kiso, M
Chiwata, T
Miyamoto, Y
Yoshimasa, Y
Fukamizu, A
Horiuchi, M
Hirata, Y
Ogawa, Y
机构
[1] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Med & Metab, Chiyoda Ku, Tokyo 1010062, Japan
[2] Tokyo Med & Dent Univ, Med Res Inst, Ctr Excellence Program Frontier Res Mol Destruct, Chiyoda Ku, Tokyo 1010062, Japan
[3] Natl Cardiovasc Ctr Hosp & Res Inst, Dept Med, Div Atherosclerosis & Diabet, Suita, Osaka 5600005, Japan
[4] Univ Tsukuba, Inst Appl Biochem, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan
[5] Ehime Univ, Sch Med, Dept Med Biochem, Onsen, Ehime 7910295, Japan
关键词
D O I
10.1210/en.2005-0003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Given that angiotensin II (AII) type 1 and 2 receptors (Agtr1 and Agtr2) are expressed in adipose tissue, AII may act directly on adipose tissue. However, regardless of whether AII directly modulates adipose tissue growth and metabolism in vivo and, if so, whether it is mediated via Agtr1 are still matters of debate. To understand the functional role of Agtr1 in adipose tissue growth and metabolism in vivo, we examined the metabolic phenotypes of mice lacking Agtr1a (Agtr1a(-/-) mice) during a high-fat diet. The Agtr1a(-/-) mice exhibited the attenuation of diet-induced body weight gain and adiposity, and insulin resistance relative to wild-type littermates (Agtr1a(+/+) mice). They also showed increased energy expenditure accompanied by sympathetic activation, as revealed by increased rectal temperature and oxygen consumption, increased expression of uncoupling protein-1 mRNA in brown adipose tissue, and increased urinary catecholamine excretion. The heterozygous Agtr1a-deficient mice (Agtr1a(+/+) mice) also exhibited metabolic phenotypes similar to those of Agtr1a(+/+) mice. Using mouse embryonic fibroblasts derived from Agtr1a(+/+) and Agtr1a(-/-) mice, we found no significant difference between genotypes in the ability to differentiate into lipid-laden mature adipocytes. In primary cultures of mouse mature adipocytes, AII increased the expression of mRNAs for some adipocytokines, which was abolished by pharmacological blockade of Agtr1. This study demonstrates that Agtr1a(-/-) mice exhibit attenuation of diet-induced weight gain and adiposity through increased energy expenditure. The data also suggest that AII does not affect directly adipocyte differentiation, but can modulate adipocytokine production via Agtr1.
引用
收藏
页码:3481 / 3489
页数:9
相关论文
共 46 条
[1]   Pathophysiological role of leptin in obesity-related hypertension [J].
Aizawa-Abe, M ;
Ogawa, Y ;
Masuzaki, H ;
Ebihara, K ;
Satoh, N ;
Iwai, H ;
Matsuoka, N ;
Hayashi, T ;
Hosoda, K ;
Inoue, G ;
Yoshimasa, Y ;
Nakao, K .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (09) :1243-1252
[2]   Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism [J].
Brink, M ;
Wellen, J ;
Delafontaine, P .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) :2509-2516
[3]   DIFFERENTIAL EXPRESSION OF ANGIOTENSIN RECEPTOR 1A AND 1B IN MOUSE [J].
BURSON, JM ;
AGUILERA, G ;
GROSS, KW ;
SIGMUND, CD .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (02) :E260-E267
[4]   Mechanisms contributing to angiotensin II regulation of body weight [J].
Cassis, LA ;
Marshall, DE ;
Fettinger, MJ ;
Rosenbluth, B ;
Lodder, RA .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1998, 274 (05) :E867-E876
[5]   Differential effects of local versus systemic angiotensin II in the regulation of leptin release from adipocytes [J].
Cassis, LA ;
English, VL ;
Bharawaj, K ;
Boustany, CM .
ENDOCRINOLOGY, 2004, 145 (01) :169-174
[6]   Renal function in the AT1A receptor knockout mouse during normal and volume-expanded conditions [J].
Cervenka, L ;
Mitchell, KD ;
Oliverio, MI ;
Coffman, TM ;
Navar, LG .
KIDNEY INTERNATIONAL, 1999, 56 (05) :1855-1862
[7]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[8]   Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].
Dahlöf, B ;
Devereux, RB ;
Kjeldsen, SE ;
Julius, S ;
Beevers, G ;
de Faire, U ;
Fyhrquist, F ;
Ibsen, H ;
Kristiansson, K ;
Lederballe-Pedersen, O ;
Lindholm, LH ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H .
LANCET, 2002, 359 (9311) :995-1003
[9]  
de Gasparo M, 2000, PHARMACOL REV, V52, P415
[10]   Angiotensin II induces catecholamine release by direct ganglionic excitation [J].
Dendorfer, A ;
Thornagel, A ;
Raasch, W ;
Grisk, O ;
Tempel, K ;
Dominiak, P .
HYPERTENSION, 2002, 40 (03) :348-354